Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor

American Journal of Physiology - Endocrinology and Metabolism

Volumn 274, Issue 4 37-4, 1998, Pages

  Andress, Dennis L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Osteoblast

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASEIN; MEMBRANE PROTEIN; PEPTIDE; PROTEIN SERINE THREONINE KINASE; SERINE; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 5 RECEPTOR; SOMATOMEDIN BINDING PROTEIN 5 [1-169]; SOMATOMEDIN BINDING PROTEIN 5 [201-218]; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING;

EID: 0031958404     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.274.4.e744     Document Type: Article

References (20)

1. Abrass, C. K., A. Berfield, and D. L. Andress. Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration. Am. J. Physiol. 273 (Renal Physiol. 42): F899-F906, 1997.
2. Andress, D. L. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells. J. Biol. Chem. 270: 28289-28296, 1995.
3. Andress, D. L., and R. S. Birnbaum. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem. 267: 22467-22472, 1992.
4. Andress, D. L., S. M. Loop, J. Zapf, and M. C. Kiefer. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem. Biophys. Res. Commun. 195: 25-30, 1993.
5. Bar, R. S., B. A. Booth, M. Boes, and B. L. Dake. Insulin-like growth factor-binding proteins from vascular endothelial cells: purification, characterization, and intrinsic biological activities. Endocrinology 125: 1910-1920, 1989.
6. Duclos, B., S. Marcandier, and A. J. Cozzone. Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis. Methods Enzymol. 201: 10-21, 1991.
7. Georgi, L. L., P. S. Albert, and D. L. Riddle. Daf-1, a C. elegans gene controlling Dauer larva development, encodes a novel receptor protein kinase. Cell 61: 635-645, 1990.
8. Hemmings, H. C., A. C. Nairn, and P. Greengard. DARPP-32, a dopamine-and adenosine 3′: 5′-monophosphate-regulated neuronal phosphoprotein. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1. J. Biol. Chem. 259: 14491-14497, 1984.
9. Jones, J. I., and D. R. Clemmons. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3-34, 1995.
10. Jones, J. I., A. Gockerman, W. H. Busby, G. Wright, and D. R. Clemmons. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA 90: 10553-10557, 1993.
11. Lin, H. Y., X. F. Wang, E. Ng-Eaton, R. A. Weinberg, and H. F. Lodish. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775-785, 1992.
12. Matthews, L. S., and W. W. Vale. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65: 973-982, 1991.
13. Mohan, S., Y. Nakao, Y. Honda, E. Landale, U. Leser, C. Dony, K. Lang, and D. J. Baylink. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J. Biol. Chem. 270: 20424-20431, 1995.
14. O'Grady, P., Q. Liu, S. S. Huang, and J. S. Huang. Transforming growth factor β (TGF-β) type V receptor has a TGF-β-stimulated serine/threonine-specific autophosphorylation activity. J. Biol. Chem. 67: 21033-21037, 1992.
15. Oh, Y., H. L. Muller, G. Lamson, and R. G. Rosenfeld. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J. Biol. Chem. 268: 14964-14971, 1993.
16. Oh, Y., H. L. Muller, H. Pham, G. Lamson, and R. G. Rosenfeld. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J. Biol. Chem. 268: 26045-26048, 1993.
17. Rajah, R., B. Valentinis, and P. Cohen. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor β-1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272: 12181-12188, 1997.
18. Slootweg, M. C., C. Ohlsson, E. J. van Elk, J. C. Netelenbos, and D. L. Andress. Growth hormone (GH) receptor activity is stimulated by insulin-like growth factor binding protein (IGFBP)-5 in rat osteosarcoma cells. Growth Reg. 6: 238-246, 1996.
19. Thrailkill, K. M., L. D. Quarles, H. Nagase, K. Suzuki, D. M. Serra, and J. L. Fowlkes. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136: 3527-3533, 1995.
20. Walton, G. M., J. Spiess, and G. N. Gill. Phosphorylation of high mobility group protein 14 by casein kinase II. J. Biol. Chem. 260: 4745-4750, 1985.